3 ASX Stocks Estimated To Be Trading Up To 49.4 percent Below Intrinsic Value
| TLX Stock | 16.86 0.08 0.48% |
Slightly above 52% of Telix Pharmaceuticals' investor base is interested to short. The analysis of overall sentiment of trading Telix Pharmaceuticals Limited stock suggests that many investors are impartial at this time. Telix Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Telix Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Telix |
The Australian stock market has shown resilience, closing nearly flat despite initial predictions of a decline and contrasting with significant drops in major U.S. indices. This unexpected stability, led by gains in sectors like Real Estate and Energy, presents an intriguing environment for identifying undervalued stocks that could offer potential value to investors. In such a market landscape, discerning intrinsic value becomes crucial for pinpointing stocks that may be trading below their...
Read at simplywall.st
 |
Telix Pharmaceuticals Fundamental Analysis
We analyze Telix Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Telix Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Telix Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Telix Pharmaceuticals is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Telix Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Telix Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Telix Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Telix Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Telix Pharmaceuticals Related Equities
| BYD | Boyd Gaming | 1.11 | ||||
| GMWKF | Games Workshop | 0.67 | ||||
| PLTK | Playtika Holding | 0.29 | ||||
| GME | GameStop Corp | 0.76 | ||||
| SNDL | SNDL | 1.11 | ||||
| MSGM | Motorsport Gaming | 1.44 | ||||
| ZM | Zoom Video | 1.72 | ||||
| SKLZ | Skillz Platform | 7.35 |
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.